Pulse Biosciences (PLSE) Long-Term Investments (2017)
Pulse Biosciences (PLSE) posted quarterly Long-Term Investments of $4.6 million for Q4 2017.
Pulse Biosciences (PLSE) Long-Term Investments (2017) Analysis & Trends
Pulse Biosciences' Long-Term Investments history runs 1 years deep, the most recent figure standing at $4.6 million for Q4 2017.
- In Q4 2017, Long-Term Investments changed N/A year-over-year to $4.6 million; the TTM figure through Dec 2017 stood at $4.6 million (changed N/A YoY), while the FY2017 annual figure was $4.6 million, changed N/A from the prior year.
- Long-Term Investments for Q4 2017 stood at $4.6 million.
- The five-year high for Long-Term Investments was $4.6 million in Q4 2017, with the low at $4.6 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 3.41 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 4.59 Mn |